Want to create an interactive transcript for this episode?
Podcast: CME
Episode: Future Directions in Managing Hyperkalemia in CKD and HF
Description:
Faculty: Javed Butler, MD, MPH, MBA
Faculty: James Burton, DM, FRCP
Patients with chronic kidney disease (CKD) and heart failure with reduced ejection fraction (HFrEF) will achieve improved benefits from optimized use of guideline directed medical therapy, however healthcare providers may not be utilizing renin–angiotensin aldosterone system inhibitors (RAASi) and mineralocorticoid receptor antagonists (MRA) use due to hyperkalemia concerns. Using a multidisciplinary approach, experts in cardiology and nephrology address the clinical implications of suboptimal RAASi and MRA use, compare real-world data on the efficacy and safety of oral potassium binders, and developing evidence-based treatment strategies that in...